The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Beta Bionics Inc shares valued at $61,524 were purchased by Sean Saint on Jun 02 ’25. At $17.89 per share, Sean Saint acquired 3,439 shares.
Also, Hopman Mark sold 868 shares, netting a total of over 15,529 in proceeds. Following the sale of shares at $17.89 each, the insider now holds 34,132 shares.
Before that, Russell Steven Jon had sold 1,039 shares from its account. In a trade valued at $18,588, the Chief Medical Officer traded Beta Bionics Inc shares for $17.89 each. Upon closing the transaction, the insider’s holdings decreased to 1,039 shares, worth approximately $1.38 million.
As published in their initiating research note from Wolfe Research on May 30, 2025, Beta Bionics Inc [BBNX] has been an Outperform and the price target has been revised to $20. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in late May. As of February 24, 2025, Stifel has initiated its “Buy” rating for BBNX. Earlier on February 24, 2025, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for BBNX stock.
Analyzing BBNX Stock Performance
During the last five days, there has been a drop of approximately -1.75%. Over the course of the year, Beta Bionics Inc shares have dropped approximately -19.13%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 18.61, which, if violated, would cause prices to drop to 18.11. In the upper region, resistance lies at 19.80. The next price resistance is at 20.49. RSI (Relative Strength Index) is 66.78 on the 14-day chart, showing neutral technical sentiment.
